335 related articles for article (PubMed ID: 21963578)
1. Effects of levosimendan on mortality and hospitalization. A meta-analysis of randomized controlled studies.
Landoni G; Biondi-Zoccai G; Greco M; Greco T; Bignami E; Morelli A; Guarracino F; Zangrillo A
Crit Care Med; 2012 Feb; 40(2):634-46. PubMed ID: 21963578
[TBL] [Abstract][Full Text] [Related]
2. Levosimendan reduces mortality in critically ill patients. A meta-analysis of randomized controlled studies.
Landoni G; Mizzi A; Biondi-Zoccai G; Bignami E; Prati P; Ajello V; Marino G; Guarracino F; Zangrillo A
Minerva Anestesiol; 2010 Apr; 76(4):276-86. PubMed ID: 20332741
[TBL] [Abstract][Full Text] [Related]
3. Levosimendan reduces cardiac troponin release after cardiac surgery: a meta-analysis of randomized controlled studies.
Zangrillo A; Biondi-Zoccai G; Mizzi A; Bruno G; Bignami E; Gerli C; De Santis V; Tritapepe L; Landoni G
J Cardiothorac Vasc Anesth; 2009 Aug; 23(4):474-8. PubMed ID: 19217315
[TBL] [Abstract][Full Text] [Related]
4. Perioperative levosimendan therapy is associated with a lower incidence of acute kidney injury after cardiac surgery: a meta-analysis.
Niu ZZ; Wu SM; Sun WY; Hou WM; Chi YF
J Cardiovasc Pharmacol; 2014 Feb; 63(2):107-12. PubMed ID: 24126568
[TBL] [Abstract][Full Text] [Related]
5. Levosimendan for the treatment of acute severe heart failure: a meta-analysis of randomised controlled trials.
Delaney A; Bradford C; McCaffrey J; Bagshaw SM; Lee R
Int J Cardiol; 2010 Feb; 138(3):281-9. PubMed ID: 18817994
[TBL] [Abstract][Full Text] [Related]
6. Effect of levosimendan on survival and adverse events after cardiac surgery: a meta-analysis.
Harrison RW; Hasselblad V; Mehta RH; Levin R; Harrington RA; Alexander JH
J Cardiothorac Vasc Anesth; 2013 Dec; 27(6):1224-32. PubMed ID: 24050857
[TBL] [Abstract][Full Text] [Related]
7. Levosimendan: a novel inotropic agent for treatment of acute, decompensated heart failure.
Earl GL; Fitzpatrick JT
Ann Pharmacother; 2005 Nov; 39(11):1888-96. PubMed ID: 16219899
[TBL] [Abstract][Full Text] [Related]
8. Levosimendan Treatment for Heart Failure: A Systematic Review and Meta-Analysis.
Gong B; Li Z; Yat Wong PC
J Cardiothorac Vasc Anesth; 2015 Dec; 29(6):1415-25. PubMed ID: 26275522
[TBL] [Abstract][Full Text] [Related]
9. Levosimendan versus dobutamine in critically ill patients: a meta-analysis of randomized controlled trials.
Huang X; Lei S; Zhu MF; Jiang RL; Huang LQ; Xia GL; Zhi YH
J Zhejiang Univ Sci B; 2013 May; 14(5):400-15. PubMed ID: 23645177
[TBL] [Abstract][Full Text] [Related]
10. Considerations on the efficacy and safety of levosimendan in ischemic heart failure.
Nieminen MS; Sandell EP
Ital Heart J; 2003 May; 4 Suppl 2():39S-44S. PubMed ID: 14635369
[TBL] [Abstract][Full Text] [Related]
11. Levosimendan reduces heart failure after cardiac surgery: a prospective, randomized, placebo-controlled trial.
Lahtinen P; Pitkänen O; Pölönen P; Turpeinen A; Kiviniemi V; Uusaro A
Crit Care Med; 2011 Oct; 39(10):2263-70. PubMed ID: 21666445
[TBL] [Abstract][Full Text] [Related]
12. Is there a place for levosimendan in the intensive care unit?
Delaney A; Bradford C; McCaffrey J; Bagshaw SM; Lee R
Crit Care Resusc; 2007 Sep; 9(3):290-2. PubMed ID: 17767458
[TBL] [Abstract][Full Text] [Related]
13. The use of levosimendan in comparison and in combination with dobutamine in the treatment of decompensated heart failure.
Cavusoglu Y
Expert Opin Pharmacother; 2007 Apr; 8(5):665-77. PubMed ID: 17376021
[TBL] [Abstract][Full Text] [Related]
14. Levosimendan in patients with low-output heart failure: lessons from the LIDO trial.
Follath F
Ital Heart J; 2003 May; 4 Suppl 2():34S-38S. PubMed ID: 14635368
[TBL] [Abstract][Full Text] [Related]
15. The calcium sensitizer levosimendan and cardiac arrhythmias: an analysis of the safety database of heart failure treatment studies.
Lilleberg J; Ylönen V; Lehtonen L; Toivonen L
Scand Cardiovasc J; 2004 May; 38(2):80-4. PubMed ID: 15204232
[TBL] [Abstract][Full Text] [Related]
16. Randomized clinical trials with levosimendan.
Mebazaa A; Barraud D; Welschbillig S
Am J Cardiol; 2005 Sep; 96(6A):74G-9G. PubMed ID: 16181826
[TBL] [Abstract][Full Text] [Related]
17. Hospital costs for treatment of acute heart failure: economic analysis of the REVIVE II study.
de Lissovoy G; Fraeman K; Teerlink JR; Mullahy J; Salon J; Sterz R; Durtschi A; Padley RJ
Eur J Health Econ; 2010 Apr; 11(2):185-93. PubMed ID: 19582491
[TBL] [Abstract][Full Text] [Related]
18. Prophylactic treatment with levosimendan: a retrospective matched-control study of patients with reduced left ventricular function.
Kolseth SM; Nordhaug DO; Stenseth R; Sellevold O; Kirkeby-Garstad I; Wahba A
Eur J Cardiothorac Surg; 2009 Dec; 36(6):1024-30. PubMed ID: 19592266
[TBL] [Abstract][Full Text] [Related]
19. Levosimendan: dual mechanisms for acute heart failure...and beyond?
Ng TM; Akhter MW
Minerva Cardioangiol; 2005 Dec; 53(6):565-84. PubMed ID: 16333239
[TBL] [Abstract][Full Text] [Related]
20. Levosimendan in acute decompensated heart failure: systematic review and meta-analysis.
Ribeiro RA; Rohde LE; Polanczyk CA
Arq Bras Cardiol; 2010 Aug; 95(2):230-7. PubMed ID: 20549133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
